1. Home
  2. EBC vs MMED Comparison

EBC vs MMED Comparison

Compare EBC & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Bankshares Inc.

EBC

Eastern Bankshares Inc.

HOLD

Current Price

$22.97

Market Cap

4.2B

Sector

Finance

ML Signal

HOLD

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$16.85

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EBC
MMED
Founded
1818
1983
Country
United States
United States
Employees
N/A
2800
Industry
Accident &Health Insurance
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.3B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
EBC
MMED
Price
$22.97
$16.85
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$22.70
$22.56
AVG Volume (30 Days)
2.3M
1.0M
Earning Date
04-23-2026
06-03-2026
Dividend Yield
3.02%
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$134,091,000.00
N/A
Revenue This Year
$80.92
$15.99
Revenue Next Year
$4.44
$10.00
P/E Ratio
$79.03
N/A
Revenue Growth
19.07
N/A
52 Week Low
$14.88
$10.65
52 Week High
$23.54
$17.86

Technical Indicators

Market Signals
Indicator
EBC
MMED
Relative Strength Index (RSI) 60.96 63.33
Support Level $19.12 $14.70
Resistance Level $23.54 N/A
Average True Range (ATR) 0.53 0.90
MACD -0.05 0.04
Stochastic Oscillator 73.66 73.31

Price Performance

Historical Comparison
EBC
MMED

About EBC Eastern Bankshares Inc.

Eastern Bankshares Inc is a commercial bank that caters its products and services to retail, commercial, and small business customers. Its diversified products and services include lending, deposit, wealth management, and insurance products. The company has one operating segment: Banking business, which offers a range of banking, lending, savings, and small business offerings, and its wealth management and trust operations.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

Share on Social Networks: